Different liposomal amphotericin B formulations for visceral leishmaniasis by Thomas P C Dorlo, Manica Balasegaram

Get full text

Pentamidine dosage: a base/salt confusion. by Thomas P C Dorlo, Piet A Kager

Get full text

Editorial: Emerging talents in Frontiers in Pharmacology: Drug metabolism and transport 2022 by Terry D. Hinds, Massimo Valoti, Yurong Lai, Thomas P. C. Dorlo, Yan Li

Get full text

Predictability of human exposure by human‐CYP3A4‐transgenic mouse models: A meta‐analysis by David Damoiseaux, Alfred H. Schinkel, Jos H. Beijnen, Alwin D. R. Huitema, Thomas P. C. Dorlo

Get full text

Power to identify exposure‐response relationships in phase IIa pulmonary tuberculosis trials with multi‐dimensional bacterial load modeling by Simon E. Koele, Thomas P. C. Dorlo, Caryn M. Upton, Rob E. Aarnoutse, Elin M. Svensson

Get full text

Failure of miltefosine treatment for visceral leishmaniasis in children and men in South-East Asia. by Bart Ostyn, Epco Hasker, Thomas P C Dorlo, Suman Rijal, Shyam Sundar, Jean-Claude Dujardin, Marleen Boelaert

Get full text

A poor-quality generic drug for the treatment of visceral leishmaniasis: a case report and appeal. by Thomas P C Dorlo, Teunis A Eggelte, Gerard J Schoone, Peter J de Vries, Jos H Beijnen

Get full text

Physiologically‐based pharmacokinetic model to predict doxorubicin and paclitaxel exposure in infants through breast milk by David Damoiseaux, Frédéric Amant, Jos H. Beijnen, Shelby Barnett, Gareth J. Veal, Alwin D. R. Huitema, Thomas P. C. Dorlo

Get full text

Predictiveness of the Human-CYP3A4-Transgenic Mouse Model (Cyp3aXAV) for Human Drug Exposure of CYP3A4-Metabolized Drugs by David Damoiseaux, Wenlong Li, Alejandra Martínez-Chávez, Jos H. Beijnen, Alfred H. Schinkel, Alwin D. R. Huitema, Thomas P. C. Dorlo

Get full text

Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice by Raffaele Simeoli, Thomas P. C. Dorlo, Lidwien M. Hanff, Alwin D. R. Huitema, Alwin D. R. Huitema, Alwin D. R. Huitema, Erwin Dreesen

Get full text

Dynamics of parasite clearance in cutaneous leishmaniasis patients treated with miltefosine. by Thomas P C Dorlo, Pieter P A M van Thiel, Gerard J Schoone, Ymkje Stienstra, Michèle van Vugt, Jos H Beijnen, Peter J de Vries

Get full text

A physiologically based pharmacokinetic model for [68Ga]Ga-(HA-)DOTATATE to predict whole-body distribution and tumor sink effects in GEP-NET patients by Hinke Siebinga, Berlinda J. de Wit-van der Veen, Jos H. Beijnen, Thomas P. C. Dorlo, Alwin D. R. Huitema, Jeroen J. M. A. Hendrikx

Get full text

High accumulation of nivolumab in human breast milk: A case report by Karen de Jong, David Damoiseaux, Dick Pluim, Hilde Rosing, Jos H. Beijnen, Hans van Thienen, Thomas P.C. Dorlo, Alwin D.R. Huitema, Frédéric Amant

Get full text

Clinical Trial Simulation To Optimize Trial Design for Fludarabine Dosing Strategies in Allogeneic Hematopoietic Cell Transplantation by Jurgen B. Langenhorst, Thomas P.C. Dorlo, Charlotte vanKesteren, Erik M. vanMaarseveen, Stefan Nierkens, Moniek A. deWitte, Jaap Jan Boelens, Alwin D.R. Huitema

Get full text

Predicting [177Lu]Lu-HA-DOTATATE kidney and tumor accumulation based on [68Ga]Ga-HA-DOTATATE diagnostic imaging using semi-physiological population pharmacokinetic modeling by Hinke Siebinga, Berlinda J. de Wit-van der Veen, Jos H. Beijnen, Marcel P. M. Stokkel, Thomas P. C. Dorlo, Alwin D. R. Huitema, Jeroen J. M. A. Hendrikx

Get full text

Population pharmacokinetic dosimetry model using imaging data to assess variability in pharmacokinetics of 177Lu‐PSMA‐617 in prostate cancer patients by Hinke Siebinga, Bastiaan M. Privé, Steffie M. B. Peters, James Nagarajah, Thomas P. C. Dorlo, Alwin D. R. Huitema, Berlinda J. deWit‐van der Veen, Jeroen J. M. A. Hendrikx

Get full text

Longitudinal nonlinear mixed effects modeling of EGFR mutations in ctDNA as predictor of disease progression in treatment of EGFR‐mutant non‐small cell lung cancer by Julie M. Janssen, Remy B. Verheijen, Tirsa T. vanDuijl, Lishi Lin, Michel M. van denHeuvel, Jos H. Beijnen, Neeltje Steeghs, Daan van denBroek, Alwin D. R. Huitema, Thomas P. C. Dorlo

Get full text

Macrophage Activation Marker Neopterin: A Candidate Biomarker for Treatment Response and Relapse in Visceral Leishmaniasis by Anke E. Kip, Monique Wasunna, Fabiana Alves, Jan H. M. Schellens, Jan H. M. Schellens, Jos H. Beijnen, Jos H. Beijnen, Jos H. Beijnen, Ahmed M. Musa, Eltahir A. G. Khalil, Thomas P. C. Dorlo

Get full text

Safety and efficacy of paromomycin/miltefosine/liposomal amphotericin B combinations for the treatment of post-kala-azar dermal leishmaniasis in Sudan: A phase II, open label, rand... by Brima Musa Younis, Ahmed Mudawi Musa, Séverine Monnerat, Mohammed Abdelrahim Saeed, Eltahir Awad Gasim Khalil, Anas Elbashir Ahmed, Mujahid Ahmed Ali, Ali Noureldin, Gina Muthoni Ouattara, Godfrey M Nyakaya, Samuel Teshome, Truphosa Omollo, Michael Ochieng, Thaddaeus Egondi, Mildred Mmbone, Wan-Yu Chu, Thomas P C Dorlo, Eduard E Zijlstra, Monique Wasunna, Jorge Alvar, Fabiana Alves

Get full text

Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. by Monique Wasunna, Simon Njenga, Manica Balasegaram, Neal Alexander, Raymond Omollo, Tansy Edwards, Thomas P C Dorlo, Brima Musa, Mohammed Hassan Sharaf Ali, Mohammed Yasein Elamin, George Kirigi, Rashid Juma, Anke E Kip, Gerard J Schoone, Asrat Hailu, Joseph Olobo, Sally Ellis, Robert Kimutai, Susan Wells, Eltahir Awad Gasim Khalil, Nathalie Strub Wourgaft, Fabiana Alves, Ahmed Musa

Get full text